Madrigal Pharmaceuticals
MDGL
$205.25
Share price
-0.81%
Change (1 day)
-28.76%
Change (1 year)
Categories
Operating Margin for Madrigal Pharmaceuticals (MDGL)
Operating Margin as of May 2024 (TTM): -42,714.30%
According to Madrigal Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -42,714.30%. At the end of 2012 the company had an Operating Margin of -42,714.29%.
Operating Margin history for Madrigal Pharmaceuticals from 2008 to 2012
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2012 | -42,714.29% | 7030.33% |
| 2011 | -599.05% | 140.33% |
| 2010 | -249.26% | -546.42% |
| 2009 | 55.84% | -101.56% |
| 2008 | -3,583.48% | -59.79% |
| 2007 | -8,911.98% | |
| 2004 | -26,211.56% | 1108.03% |
| 2003 | -2,169.79% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -99.91% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | -80.36% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.